N.W.S. SRL
N.W.S. reported revenue of 81,008 € for the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).
The score of N.W.S. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -83 % Equity +14 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
N.W.S.'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 81,008 € | ||||
| Net result | 9,253 € | ||||
| Equity | 220,555 € | ||||
| Cash | 22,481 € | ||||
| EBITDA | 5,522 € | ||||
| Total assets | 256,164 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
N.W.S.'s financial analysis
- Solvency86.1%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of N.W.S.
N.W.S.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0861.238.056
- VAT number
- BE0861238056
- Peppol
- Registered · 0208:0861238056 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Oct 2003
- Registered office
- 1703 Dilbeek
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
N.W.S. (SRL) has been based in Dilbeek since 2003, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports revenue of 81,008 €, a net profit of 9,253 € and equity of 220,555 €. Its solvency stands at 86.1%, above the median of its sector (47.4%).
Companies similar to N.W.S.
Companies in the same business, of comparable size and area, outside its group.
- Toba Company Retail sale of medical and orthopaedic goods Ninove · balance sheet 294,918 €
- Dental SUD Retail sale of medical and orthopaedic goods Namur · balance sheet 34,848 €
- Elmax Medical Retail sale of medical and orthopaedic goods Roeselare · balance sheet 257,014 €
- Symphonie Scheffers Retail sale of medical and orthopaedic goods Overijse · balance sheet 246,779 €
- VBrep Retail sale of medical and orthopaedic goods Gerpinnes · balance sheet 350,554 €
- Cabinet Infirmier Falisse-Audin Retail sale of medical and orthopaedic goods Charleroi · balance sheet 257,182 €
- LES Ombelles Retail sale of medical and orthopaedic goods Saint-Gilles · balance sheet 174,420 €
- Exendo Epigenomics Retail sale of medical and orthopaedic goods Herentals · balance sheet 328,329 €
Frequently asked questions about N.W.S.
What is the revenue of N.W.S.?
According to the 2025 annual accounts filed with the NBB, the revenue of N.W.S. amounts to 81,008 €.
What is the VAT number of N.W.S.?
In Belgium, the VAT number is the company number prefixed with BE: BE0861238056 for N.W.S., if the company is VAT-registered. Its company number (CBE) is 0861.238.056.
Where is the registered office of N.W.S.?
According to the CBE register, the registered office of N.W.S. is in 1703 Dilbeek.
What is the equity of N.W.S.?
At the close of the 2025 financial year, the equity of N.W.S. amounts to 220,555 €, a solvency of 86.1% of total assets.
Who manages N.W.S.?
The register lists 1 active mandates at N.W.S.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of N.W.S.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →